Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

25 terminated/withdrawn out of 250 trials

Success Rate

86.0%

-0.6% vs industry average

Late-Stage Pipeline

10%

24 trials in Phase 3/4

Results Transparency

11 of 153 completed trials have results

Key Signals

41 recruiting11 with results12 terminated13 withdrawn

Enrollment Performance

Analytics

N/A

89(59.3%)

Phase 2

32(21.3%)

Phase 4

14(9.3%)

Phase 3

10(6.7%)

Phase 1

4(2.7%)

Early Phase 1

1(0.7%)

150Total

N/A(89)

Phase 2(32)

Phase 4(14)

Phase 3(10)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (250)

Showing 20 of 250 trials

NCT07634185Early Phase 1Not Yet Recruiting

Clinical Evaluation of an AI Risk Prediction System (AI-TRiPS)

Role: collaborator

NCT04141592Recruiting

Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease

Role: collaborator

NCT04995224Recruiting

Mechanism of Chronic Pain in Patients With IBD

Role: collaborator

NCT03684564Phase 2Completed

RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome

Role: collaborator

NCT04327817Phase 4Completed

Multifidus PET Scan Study

Role: lead

NCT06165510Not ApplicableRecruiting

Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation

Role: lead

NCT00461188Recruiting

Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA

Role: lead

NCT05727020Recruiting

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma

Role: collaborator

NCT07574697Recruiting

AIC Genotyping Study

Role: lead

NCT04170491Not ApplicableRecruiting

EEG Monitoring for Refractory Status Epilepticus

Role: lead

NCT05633303Not ApplicableRecruiting

Personalised Ablation Strategies in AF

Role: lead

NCT06731543Completed

Development of an AF Specific Quality of Life Questionnaire: AF-PROMS

Role: lead

NCT07551765Not Yet Recruiting

Diet-drive Gut Microbiome and Outcome in Patients With Early-stage Triple-negative Breast Cancer Undergoing Neoadjuvant Chemotherapy and Immunotherapy.

Role: lead

NCT06086873Not ApplicableRecruiting

Investigating Implant Surface Effect on Osseointegration: NGA vs. ModSLA

Role: lead

NCT05920824Recruiting

Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation

Role: lead

NCT05781113Active Not Recruiting

A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Condition

Role: collaborator

NCT07051005Not ApplicableRecruiting

Feasibility of a Tailored Online Self-compassion Intervention

Role: collaborator

NCT06453733Not ApplicableRecruiting

Crainio Non-invasive ICP Monitor for TBI

Role: collaborator

NCT05369130Recruiting

Investigate and Predict Aortic & Thoracic Surgery Persistenet Postsurgical Pain

Role: collaborator

NCT06022848Not ApplicableCompleted

Quantitative Sensory Testing and Occipital Nerve Stimulator

Role: lead